Clinical Trials Logo

Clinical Trial Summary

The goal of this study is to evaluate the effect of white matter guided theta burst stimulation on episodic memory task performance in healthy older adults. The investigators aim to propagate the effect of theta burst stimulation from a superficial locus of stimulation (angular gyrus) to hippocampus and parahippocampal regions using white matter tract connection between these regions. Study activities and population group - for the study plans to recruit 20 healthy older adults who already have white matter scans acquired as part of another study performed by the Cabeza Lab at Duke University.

Using tractography the exact site of stimulation on the cortical surface will be localized. An initial motor evoked potential (MEP) assessment will differentiate responders to theta burst stimulation from non responders. Responders will receive 1200 pulses of intermittent theta burst stimulation (iTBS) or sham stimulation to the angular gyrus while they perform the encoding portion of an episodic memory task. There after, they will perform retrieval piece of the task and data analysis will compare these performances.


Clinical Trial Description

Aims and Hypotheses The purpose of the study is to evaluate the effect of theta burst stimulation (TBS) which is a relatively new paradigm of transcranial magnetic stimulation (TMS) on episodic memory (EM) in healthy older adults (hOA).

Aim1: Evaluate the effect of theta burst stimulation (TBS) on episodic memory (EM) in healthy older adults. Hypothesis 1 - There will be significant improvement in EM compared to baseline with one session of TBS.

Aim 2: Correlate white matter integrity to improvement in task retrieval with TBS. Hypothesis 2- Stronger white matter (WM) tract connections correlate to greater improvement in retrieval performance.

BACKGROUND Alzheimer's disease (AD) affects 5 million Americans, at a cost of over 200 billion dollars. The first and most debilitating symptom of AD is a severe deficit in the ability to remembering personal past events, or episodic memory (EM), which eventually renders patients isolated from family and friends and unable to live independently. This EM deficit reflects primarily the deterioration of medial temporal lobe regions, particularly the hippocampus (HC). AD treatments must start very early in the disease progression, when brain damage is still small, and the earliest stage when AD can be diagnosed is known as mild cognitive impairment due to AD (MCI-AD).

Recently, different forms of noninvasive brain stimulation techniques have been applied to healthy older adults, AD and MCI-AD to improve memory impairment. Most of these trials used high-frequency repetitive transcranial magnetic stimulation (rTMS) applied to the left dorsolateral prefrontal cortex (DLPFC). Although a small number of these studies have shown beneficial effects, considerable questions remain as to whether TMS has clinically relevant effects in elderly populations, as well as to what neuroscience-based mechanisms account for these effects. An obstacle for using TMS to enhance EM is that the brain region most critical for EM and most affected by early AD, the hippocampus (HC), is situated deep inside the brain, beyond TMS direct effects (~1" below the skull). One study attempted to target hippocampus and peri-hippocampal regions for stimulation via TMS. They stimulated the lateral parietal cortex and utilized functional connectivity between this region and hippocampus/peri-hippocampal regions (mainly entorhinal cortex) to enhance performance on an associative memory task. The inferior longitudinal fasciculus connects angular gyrus to hippocampus and para-hippocampal regions, and could propagate stimulation effects from cortical to subcortical structures, although studies on effect on TMS on white matter neuronal populations are limited as detailed below. The effect of TMS on neuronal populations in the white matter tracts was recently modeled using tractography and e-field calculations, and increasingly, these approaches need to account for what percentage of variance in motor threshold (MT) would be accounted for by white matter tracts.

TBS is a potent paradigm of TMS. As detailed in a seminal paper by Huang et al, there are 2 patterns for the paradigm: - continuous theta burst stimulation (cTBS) and intermittent theta burst stimulation (iTBS). The former produces suppression of MEP and the latter produces increase in MEP. iTBS delivers 50 Hz stimuli in packets of 10 lasting 2 seconds. Each stimulus burst delivered at 50 Hz is given every 200 milliseconds making the overall frequency of stimulus delivery 5 Hz. Hence the stimulation encompasses nested 50 Hz bursts (gamma frequency) given at 5 Hz (theta frequency). Most investigational studies which did not have treatment outcome measures have used either 40 second of cTBS or 190 seconds of iTBS. Both these paradigms have been shown to cause changes in MEP for 60 minutes. Variations in pattern of stimulation have also been effective, although there are limited studies to warrant its use. The investigators therefore propose to use stimulate the function of the hippocampal formation in healthy older adults (hOA) by targeting a cortical region directly connected to the hippocampal formation: the angular gyrus. To increase indirect effects on hippocampal formation, the investigators will use the most powerful TMS technique available, intermittent Theta Burst Stimulation (iTBS).

METHODOLOGY The study is designed to be a pilot one evaluating the effect of TBS on EM in healthy older adults (hOA). The investigators plan to screen 30 participants to select 20 subjects.

Screening Potential participants will be in the age group of 60-80 years and encompasses subjects who have been recruited to previous studies at Cabeza Lab (Pro00005021), hence having brain imaging data already collected.

Study procedure On day 1 of the study, subjects will have the National Institute of Health (NIH) Toolbox administered to them. The NIH toolbox is a comprehensive set of neuro-behavioral measurements that quickly assesses cognitive functions from the convenience of an iPad. Total time allotted for NIH toolbox administration is 45 minutes. Following this, subjects will have motor evoked potential (MEP) performed after which they will be administered intermittent theta burst stimulation (iTBS) to motor cortex. This will be followed by measurement of motor evoked potential (MEP) again. Subjects who do not show a 10 % increase in motor evoked potential (MEP) with iTBS will be excluded from further parts of the study.

Our study uses a specific kind of TMS, known as intermittent theta burst stimulation (iTBS). On day 1 of the study, subjects will be administered either left-sided iTBS to the motor cortex. The subject will be seated in a chair. Electromyogram (EMG) electrodes will be applied to the right hand for motor evoked potential (MEP) recording. For iTBS the active motor threshold would be 80 % as used in most theta burst studies detailed in this review. Subjects would receive iTBS comprising 50 Hz bursts given at 3 to 5 Hz for close to 3 minutes which comprises 19 trains and 600 pulses. The subject will be monitored until MEPs return to baseline. A side effects checklist will be completed at the beginning and at the end of the experimental session. All sessions will be performed by one of the protocol investigators, or by a trained and accredited research assistant supervised by the protocol investigators.

If a 10 % increase is seen in the MEP, then subjects will receive a second session of iTBS or sham stimulation to the left angular gyrus one hour after the screening session. If they receive iTBS, this will comprise 6 minutes of stimulation equivalent to 1200 pulses and 38 trains of the stimulus. The subject will be monitored until MEPs return to baseline. A side effects checklist will be completed at the beginning and at the end of the experimental session. Sham stimulation will use superficial electrodes to mimic the experience of receiving actual stimulation. All sessions will be performed by one of the protocol investigators, or by a trained and accredited research assistant supervised by the protocol investigators. Subjects will perform encoding trials of episodic memory task with stimulation and retrieval piece of the task after the stimulation. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03406195
Study type Interventional
Source Duke University
Contact
Status Withdrawn
Phase N/A
Start date December 15, 2018
Completion date December 30, 2019

See also
  Status Clinical Trial Phase
Completed NCT05433233 - Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension N/A
Recruiting NCT06032065 - SMART Exercise for PAD Phase 3
Active, not recruiting NCT05293730 - Trial of the Impact of the Electronic Frailty Integrated With Social Needs N/A
Recruiting NCT03932162 - Gene Expression Changes In Young and Geriatric Skin Early Phase 1
Completed NCT04064528 - Effects of Age on Amino Acid Delivery to Tendon N/A
Active, not recruiting NCT03366129 - Blood-Brain Barrier Disruption in People With White Matter Hyperintensities Who Have Had a Stroke
Completed NCT06029920 - Influence of Overground Walking on Biomarkers, Cognitive Function, and Quality of Life in Elderly With Mild Cognitive Impairment N/A
Recruiting NCT05566938 - Study to Design a Precision Nutrition Strategy at a Group Level in the Elderly N/A
Recruiting NCT05543980 - Leg Heat Therapy in Elderly Individuals Phase 2
Completed NCT04894929 - Comprehensive Geriatric Assessment in the Monitoring of Functional Improvement N/A
Not yet recruiting NCT06071130 - Emotion, Aging, and Decision Making N/A
Enrolling by invitation NCT04641663 - Multi-target Dietary Supplement Tolerability in an Aging Population (MTDSST) N/A
Completed NCT04088006 - The Evaluation of Efficacy and Safety of Hyaluronic Acid Injection on Skin Moisturization and Elasticity N/A
Completed NCT03695081 - Patient Pathway Pharmacist - Optimal Drug-related Care N/A
Recruiting NCT05424263 - Acetate and Age-associated Arterial Dysfunction Phase 2
Completed NCT05601713 - Mitigating Heat-induced Physiological Strain and Discomfort in Older Adults Via Lower Limb Immersion and Neck Cooling N/A
Completed NCT04551339 - Zinc Versus Multivitamin Micronutrient Supplementation in the Setting of COVID-19 N/A
Recruiting NCT04997577 - Speech Perception and High Cognitive Demand N/A
Completed NCT05922475 - Efficacy of Pre-sleep or Post-exercise Protein During 12 Weeks of Resistance Exercise Training N/A
Completed NCT04015479 - Peanut Protein Supplementation to Augment Muscle Growth and Improve Markers of Muscle Quality and Health in Older Adults N/A